Leukemia and Lymphoma : Impact Factor & More
eISSN: 1029-2403pISSN: 1042-8194
Share this on:
Key Metrics
CiteScore 
4.2
Impact Factor
< 5
SNIP
0.79
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Leukemia and Lymphoma Journal Specifications
Indexed in the following public directories
Scopus 
SJR
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1989 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Leukemia and Lymphoma ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Leukemia and Lymphoma
Asparaginase activity levels and toxicity in children and adolescents with acute lymphoblastic leukemia
- 24 Apr 2026
- Leukemia & Lymphoma
A real-world multicenter study of first-line zanubrutinib-based therapy for diffuse large B-cell lymphoma
- 22 Apr 2026
- Leukemia & Lymphoma
MBP1 inhibits AML proliferation through downregulating noncanonical Wnt/Ca2+ signaling pathway
- 22 Apr 2026
- Leukemia & Lymphoma
Molecular deconstruction of anaplastic large cell Lymphoma (ALCL)
- 21 Apr 2026
- Leukemia & Lymphoma
Defined genetic abnormalities shape the clonal hierarchy in acute myeloid leukemia as founding events
- 21 Apr 2026
- Leukemia & Lymphoma
Clinicopathological factors associated with the prognosis and relapse of primary cutaneous marginal zone lymphoma: a retrospective cohort study
- 21 Apr 2026
- Leukemia & Lymphoma
Asparaginase activity levels and toxicity in children and adolescents with acute lymphoblastic leukemia
- 24 Apr 2026
- Leukemia & Lymphoma
A real-world multicenter study of first-line zanubrutinib-based therapy for diffuse large B-cell lymphoma
- 22 Apr 2026
- Leukemia & Lymphoma
MBP1 inhibits AML proliferation through downregulating noncanonical Wnt/Ca2+ signaling pathway
- 22 Apr 2026
- Leukemia & Lymphoma
Molecular deconstruction of anaplastic large cell Lymphoma (ALCL)
- 21 Apr 2026
- Leukemia & Lymphoma
Defined genetic abnormalities shape the clonal hierarchy in acute myeloid leukemia as founding events
- 21 Apr 2026
- Leukemia & Lymphoma
Clinicopathological factors associated with the prognosis and relapse of primary cutaneous marginal zone lymphoma: a retrospective cohort study
- 21 Apr 2026
- Leukemia & Lymphoma
FAQs on Leukemia and Lymphoma
How long has Leukemia and Lymphoma been actively publishing? 
What is the publishing frequency of Leukemia and Lymphoma?
How many articles did Leukemia and Lymphoma publish last year?
What is the eISSN & pISSN for Leukemia and Lymphoma?
What is Citescore for Leukemia and Lymphoma?
What is SNIP score for Leukemia and Lymphoma?
Who is the publisher of Leukemia and Lymphoma?
